10/66 Dementia Research Group randomised controlled trial: helping carers to care - Russia

Conditions

Dementia syndrome Mental and Behavioural Disorders Dementia

Gavrilova SI, Ferri CP, Mikhaylova N, Sokolova O, Banerjee S, Prince M.

2009-04-0169 citations

The protocols for the 10/66 dementia research group population-based research programme.

Prince M, Ferri CP, Acosta D, Albanese E, Arizaga R, Dewey M, Gavrilova SI, Guerra M, Huang Y, Jacob KS, Krishnamoorthy ES, McKeigue P, Rodriguez JL, Salas A, Sosa AL, Sousa RM, Stewart R, Uwakwe R.

2007-07-20243 citations

10.1186/1471-2458-7-165

Interventions

60 caregivers of people with dementia in each centre were randomised to receive the intervention immediately (n = 30) or six months later (n = 30). The 10/66 intervention targets the main carer, but i

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged 65 years and over 2. Meet Diagnostic and Statistical Manual of mental disorders fourth edition (DSM-IV) criteria for dementia syndrome

Exclusion criteria

Exclusion criteria: 1. Serious intercurrent illness (e.g. terminal illness) in the person with dementia, where the intervention might seem pointless to the family 2. A complete absence of family caregivers

Design outcomes

Primary

Measure	Time frame
Caregiver psychological distress (SRQ-20) which is assessed at baseline and after six months.	—

Secondary

Measure	Time frame
1. Caregiver: 1.1. Zarit Burden Interview 1.2. Quality of Life, measured with the World Health Organisation Quality of Life Assessment (WHO-QoL BREF) 2. Person with dementia: 2.1. Behavioural and Psychological symptoms (Neuropsychiatric Inventory Questionnaire [NPI-Q]) 2.2. Quality of life, measured using the Dementia Quality Of Life instrument (DEMQOL) All secondary outcomes will be measured at baseline and six months.	—

Measure

Time frame

1. Caregiver: 1.1. Zarit Burden Interview 1.2. Quality of Life, measured with the World Health Organisation Quality of Life Assessment (WHO-QoL BREF) 2. Person with dementia: 2.1. Behavioural and Psychological symptoms (Neuropsychiatric Inventory Questionnaire [NPI-Q]) 2.2. Quality of life, measured using the Dementia Quality Of Life instrument (DEMQOL) All secondary outcomes will be measured at baseline and six months.

—

Countries

Russian Federation

Outcome results

None listed